John E. Trusheim
Expertise in
22
conditions

Dr. John E. Trusheim

Neurology
Noran Neurological Clinic, P.A.
3601 Minnesota Dr, Suite 200, 
Bloomington, MN 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Expertise in
22
conditions
Noran Neurological Clinic, P.A.
3601 Minnesota Dr, Suite 200, 
Bloomington, MN 

Overview

John Trusheim is a Neurologist practicing medicine in Bloomington, Minnesota.

Dr. Trusheim is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Dr. Trusheim is board certified in American Board Of Psychiatry And Neurology,2011, Neurology, Sleep Medicine, and 1989. He is actively involved in clinical research, co-authoring 5 peer reviewed articles and participating in 6 clinical trials. Dr. Trusheim is currently accepting new patients.

Specialties

Neurology

Licenses

Psychiatry & Neurology in MN

Board Certifications

American Board Of Psychiatry And Neurology,2011
Neurology
Sleep Medicine
1989

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Martin's Point Generations
  • MEDICARE MAPD
  • OTHER MEDICARE
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Primewest Health System
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
Sunshine Health
  • EPO
  • HMO
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

NORAN NEUROLOGICAL CLINIC, P.A.
3601 Minnesota Dr, Suite 200, Bloomington, MN 55435

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
Enrollment Status: Recruiting
Publish Date: July 30, 2026
Intervention Type: Drug, Radiation, Biological
Study Drugs: Temozolomide, Lomustine, Regorafenib, Paxalisib, VAL-083
Study Phase: Phase 2/Phase 3
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: October 31, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
Enrollment Status: Suspended
Publish Date: April 03, 2024
Intervention Type: Biological
Study Phase: Phase 3
A Phase I/II Study of the Combination of Indoximod and Temozolomide for Adult Patients With Temozolomide-Refractory Primary Malignant Brain Tumors
A Phase I/II Study of the Combination of Indoximod and Temozolomide for Adult Patients With Temozolomide-Refractory Primary Malignant Brain Tumors
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Drug, Radiation
Study Phase: Phase 1/Phase 2
Open-label, Randomized, Controlled, Phase 3 Safety and Efficacy Study of Trans Sodium Crocetinate With Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
Open-label, Randomized, Controlled, Phase 3 Safety and Efficacy Study of Trans Sodium Crocetinate With Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
Enrollment Status: Terminated
Publish Date: July 22, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment Status: Terminated
Publish Date: February 07, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
View 5 Less Clinical Trials

5 Total Publications

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.
Journal: JAMA oncology
Published: November 17, 2022
Similar Doctors
Expertise in
9
conditions
Expertise in
9
conditions
Referral may be required

M Health Fairview Neurology Clinic Minneapolis

909 Fulton Street Southeast, Floor 3, 
Minneapolis, MN 
 (8.9 miles away)
612-626-6688
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jerrold Vitek is a Neurologist practicing medicine in Minneapolis, Minnesota. Dr. Vitek is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, Deep Brain Stimulation, and Vagotomy. Dr. Vitek is board certified in Neurology: American Board Of Psychiatry And Neurology, 1992. Dr. Vitek is currently accepting new patients.

Expertise in
41
conditions
Expertise in
41
conditions
Referral may be required

Park Nicollet Struthers Parkinson's Center

6701 Country Club Dr, 
Golden Valley, MN 
 (8.7 miles away)
952-993-5495
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

I am a board-certified neurologist and clinical geneticist with special interest in movement disorders, such as Parkinson's disease, Huntington's disease, hereditary ataxias and spastic paraplegias, as well as other neurogenetic disorders. I have served as the medical director of the Struthers Parkinson's Center since 2000. In addition to the care of patients and families with neurologic diseases, I am also involved in clinical research to develop better treatments for Parkinson's disease and Huntington's disease. I am interested in education for both patients and medical professionals. I currently serve as a clinical professor of neurology at the University of Minnesota. My other current regional and national professional activities are as follows: • Medical Advisor, Minnesota Chapter of the Huntington's Disease Society of America, 1992 – current • Chair, Scientific Advisory Board for the Spastic Paraplegia Foundation, 2003 – current • Member, Steering Committees for KINECT-HD and GENEPDAssociate Editor, Journal of Huntington’s Disease. Dr. Nance is highly rated in 41 conditions, according to our data. Her clinical expertise encompasses Huntington Disease, Movement Disorders, Parkinson's Disease, and Mcleod Neuroacanthocytosis Syndrome. Dr. Nance is board certified in American Board Of Med Genetics And Genomics-Clinical Genetics & Genomics and American Board Of Psych & Neuro-Neurology. Dr. Nance is currently accepting new patients.

Expertise in
51
conditions
Dr. William B. Dobyns
Pediatrics | Neurology | Medical Genetics
Expertise in
51
conditions
Dr. William B. Dobyns
Pediatrics | Neurology | Medical Genetics
Referral may be required

M Health Fairview Explorer Pediatric Specialty Clinic

2450 Riverside Avenue, Floor 12, 
Minneapolis, MN 
 (8.5 miles away)
612-365-6777
Experience:
48+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Dobyns is a Pediatrics specialist and a Neurologist practicing medicine in Minneapolis, Minnesota. He has been practicing medicine for over 48 years. Dr. Dobyns is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Increased Head Circumference, Lissencephaly, Cerebellar Hypoplasia, and Cortical Dysplasia. Dr. Dobyns is board certified in Clinical Genetics And Genomics: American Board Of Medical Genetics And Genomics, 1987. Dr. Dobyns is currently accepting new patients.

Frequently Asked Questions about Dr. John E. Trusheim

How do I make an appointment with Dr. John E. Trusheim?

You can book an appointment with Dr. John E. Trusheim by calling their office at 612-879-1000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. John E. Trusheim a top-rated expert for Glioblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. John E. Trusheim is classified as an Distinguished expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. John E. Trusheim specialize in?

While Dr. John E. Trusheim is a Neurology, they have specific expertise in Glioblastoma, Astrocytoma, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. John E. Trusheim participate in research or clinical trials?

Yes. Dr. John E. Trusheim has published 5 articles and abstracts on conditions like Glioblastoma. You can view a list of Dr. John E. Trusheim's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. John E. Trusheim accept my insurance?

Dr. John E. Trusheim accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 612-879-1000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Trusheim's expertise for a condition
ConditionClose
    View All 16 Distinguished Conditions
    View All 22 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile